tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Adnan Butt, 51 are a BUY (82.26%), 6 are a HOLD (9.68%), 5 are a SELL (8.06%).
Analyst Adnan Butt, currently employed carries an average stock price target met ratio of 82.92% that have a potential upside of 97.45% achieved within 630 days. Previously, Adnan Butt worked at GUGGENHEIM, RBC.
Adnan Butt’s has documented 103 price targets and ratings displayed on 8 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on REGN, Regeneron Pharmaceuticals at 22-Feb-2019.
Analyst best performing recommendations are on MDCO (THE MEDICINES COMPANY).
The best stock recommendation documented was for MNKD (MANNKIND CORP) at 11/4/2015. The price target of $5 was fulfilled within 62 days with a profit of $9.95 (66.56%) receiving and performance score of 10.73.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
4 years 11 months 22 days ago
(26-Nov-2019)
8/8 (100%)
$7.31 (15.33%)
148
Hold
$85
$0.1 (0.12%)
$85
4 years 11 months 22 days ago
(26-Nov-2019)
3/6 (50%)
$1.12 (1.34%)
950
Hold
$85
$0.1 (0.12%)
$100
4 years 11 months 23 days ago
(25-Nov-2019)
0/4 (0%)
$1.2 (1.43%)
Buy
$68
$-16.9 (-19.91%)
$68
4 years 11 months 23 days ago
(25-Nov-2019)
4/6 (66.67%)
$-15.8 (-18.85%)
235
Buy
$60
$-24.9 (-29.33%)
$55
5 years 17 days ago
(31-Oct-2019)
5/5 (100%)
$7.51 (14.31%)
205
What Year was the first public recommendation made by Adnan Butt?
